Skip to main content
Clinical Trials/NCT04031781
NCT04031781
Completed
Not Applicable

The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis

Ain Shams University0 sites33 target enrollmentMay 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Episodic Migraine
Sponsor
Ain Shams University
Enrollment
33
Primary Endpoint
Migraine attack frequency
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of the study was to examine the prophylactic role of repetitive transcranial magnetic stimulation (rTMS) on the frequency, and severity of migraine attacks in episodic migraineurs who failed medical treatment.

A group received 5 rTMS sessions, delivered over one week. Each rTMS session consisted of a single train of 900 total pulses over 3 minutes duration given at 5-Hz frequency and 100% motor threshold intensity and the placebo group received rTMS with the same stimulation frequency at a fixed intensity of 50% of the machine output

Registry
clinicaltrials.gov
Start Date
May 1, 2013
End Date
February 1, 2015
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tamer Emara

Assistant professor of neurology

Ain Shams University

Eligibility Criteria

Inclusion Criteria

  • cases diagnosed as episodic migraine with or without aura according to the ICHD 3rd edition
  • With a headache frequency of 4-14 per month for the last six months
  • Patients who had either an unsatisfactory response, declined or were intolerant to at least two prophylactic medications.

Exclusion Criteria

  • Patients with past family history of seizures
  • Other chronic pain disorders
  • Severe depression (Beck Depression Inventory of 30 or more)
  • Other significant neurologic or psychiatric diagnosis including substance misuse
  • Metal implants in the head
  • Pregnant or breastfeeding ladies
  • Prior experience with TMS

Outcomes

Primary Outcomes

Migraine attack frequency

Time Frame: 2 months

The primary outcome measure was defined as the reduction of number of migraine attacks by at least 50% after rTMS sessions.

Secondary Outcomes

  • Functional disability(2 months)
  • Use of abortive pills(2 months)
  • Migraine days(2 months)
  • Migraine attack severity(2 months)

Similar Trials